孟麗榮 MENG LI RONG, GRACE

教授 Professor
 

電郵 Email: lrmeng@mpu.edu.mo
辦公室電話 Tel: 8599 3449
辦公室Office: 明德樓 (MENG TAK)-7/F, M730


學歷 Academic qualifications
-
CHINA MEDICAL UNIVERSITY - 醫學博士 (2005)
-
JIANGXI MEDICAL COLLEGE - BACHELOR OF MEDICINE (1983)

個人簡介 Biography
  • 國家科技部項目評審專家庫專家
  • 國家科學技術獎勵評審專家庫專家

出版 Publications

(Publications in SCI - listed Journals—2012-2019)

  • Meng LI Rong .Effects of cordycepin, gold nanostar, and their combination on endometrial cancer cells. Natural Product Communications, 2020, 15(8): 1-9
  • Meng LI Rong .Antitumor effects of mrs5698, a cordycepin derivative, on endometrial cancer cells. Natural product communications, 2019, 14(10):1–7
  • Meng LI Rong. In silico and in vitro anti-helicobacter pylori effects of combinations of phytochemicals and antibiotics. Molecules, 2019, 24(19): reference no.3608
  • Meng Lirong. Long non-coding RNA CDKN2B antisense RNA 1 gene contributes to Paclitaxel resistance in endometrial carcinoma. Frontiers in Oncology, 2019(9), article no. 27
  • Meng Lirong. lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer. Molecular Therapy - Nucleic Acids, 2019(16):257-271
  • Meng Lirong. Elder abuse and its impact on quality of life in nursing homes in China. Archives of Gerontology and Geriatrics, 2018(78):155-159
  • Meng Lirong . Experimental and in silico analysis of cordycepin and its derivatives as endometrial cancer treatment. Oncology Research. 2018
  • Meng Lirong . Long non-coding RNA tumor suppressor candidate 7 advances chemotherapy sensitivity of endometrial carcinoma through targeted silencing of miR-23b .Tumor Biology. June 2017: 1–8
  • Meng Lirong .Quality of life and clinical correlates in older adults living in the community and in nursing homes in Macao. PSYCHOGERIATRICS 2017
  • Meng Lirong .Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study. Experimental Biology and Medicine,2017; 0: 1-13
  • Meng Lirong .Targeted Silencing of S100A8 Gene by miR-24 to Increase Chemotherapy Sensitivity of Endometrial Carcinoma Cells to Paclitaxel. Medical Science Monitor, 2016(22): 1953-1958
  • Meng Lirong .Effect of mTOR Inhibitors in Nude Mice with Endometrial Carcinoma and Variable PTEN Expression Status. Medical Science Monitor Basic Research, 2014, 20:146-152
  • Meng Lirong .The multi-targeted kinase inhibitor sorafenib inhibits enterovirus 71 replication by regulating IRES-dependent translation of viral proteins. Antiviral Research,106(2014):80–85/ISSN 0166-3542
  • Meng Lirong. Suppression of HER-2 via siRNA interference promotes apoptosis and decreases metastatic potential of SKOV‑3 human ovarian carcinoma cells. Oncology Reports, 2013, 29(3): 1133-1139
  • Meng Lirong. EGFR- and AKT-mediated reduction in PTEN expression contributes to tyrphostin resistance and is reversed by mTOR inhibition in endometrial cancer cells. Molecular and Cellular Biochemistry,2012,361(1-2):19-29
  • Meng Lirong. MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2. Med Sci Monit, 2012; 18(4): BR149-155

Books

  • Meng Lirong (Editor in Chief). Endometrial Carcinoma Theory and Practice. Sciences and technology book concern Liaoning, 2010.
  • Meng Lirong (Editor in Chief). The Colour Atlas of The Applied Anatomy--The Pelvic and The Hip. Sciences and technology book concern Liaoning, 2010.
  • Meng, Lirong. (Subeditor). The Colour Atlas of The Applied Anatomy of The Skull, The Brain and The Neck. Sciences and technology book concern Liaoning, 2006.

Awards

  • 2008 Liaoning Provincial S&T Award (Second Prize)
  • 2008 Shenyang S&T Progress Award (Third Prize)

發明專利

  • 中華人民共和國國家知識產權局,發明專利,專利號: ZL 2016 1 1183912.2
    一種人子宮内膜癌細胞系及其建立方法 (2019.09)

科研興趣 Research interests

最近兩年任教科目 Subjects taught in last two years
-
高級健康評估(ADVANCED HEALTH ASSESSMENT) 2021/2022
-
高級病理生理學(ADVANCED PATHOPHYSIOLOGY) 2021/2022
-
解剖生理學(ANATOMY AND PHYSIOLOGY) 2021/2022
-
基礎生物(GENERAL BIOLOGY) 2021/2022
-
病理生理學(PATHOPHYSIOLOGY) 2021/2022
-
研究方法(RESEARCH METHODS) 2021/2022
-
論文(THESIS) 2021/2022
-
專題習作I(THESIS I) 2021/2022
-
專題習作II(THESIS II) 2021/2022